Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Taejoon Pharmaceutical Co., Ltd.
FDA Inspection
•Taejoon Pharmaceutical Co., Ltd.•October 15, 2019

Taejoon Pharmaceutical Co., Ltd. – FDA Inspection, Oct 15, 2019

Record Details

This FDA Inspection record concerns Taejoon Pharmaceutical Co., Ltd., with an inspection on October 15, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Taejoon Pharmaceutical Co., Ltd.
Inspection Date
October 15, 2019
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 125fb7e3-c092-4586-abaa-5795bc47b8de

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1106379
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

12
  1. 21 CFR 211.68(b)Computer control of master formula records
  2. 21 CFR 211.160(b)(3)Drug product sample
  3. 21 CFR 211.165(b)Microbiological testing
  4. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  5. 21 CFR 211.160(a)Following/documenting laboratory controls
  6. 21 CFR 211.160(b)Scientifically sound laboratory controls
  7. 21 CFR 211.194(a)Complete test data included in records
  8. 21 CFR 211.42(c)(10)Aseptic Processing Area
  9. 21 CFR 211.192Investigations of discrepancies, failures
  10. 21 CFR 211.22(d)Procedures not in writing, fully followed

Showing 10 of 12 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Taejoon Pharmaceutical Co., Ltd.

3
DateClassificationOfficeProject area
October 18, 2022VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 18, 2018Not classifiedOffice of Inspections and Investigations
November 15, 2016VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Taejoon Pharmaceutical Co., Ltd.
  • FDA Inspection 1182340 - 2022-10-18
  • FDA Inspection 1068405 - 2018-09-18
  • FDA Inspection 994512 - 2016-11-15

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Taejoon Pharmaceutical Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.